C erebral ischemia launches multiple rapid immune responses, characterized by the activation of resident microglia, the infiltration of peripheral immune cells such as macrophages and lymphocytes, and the accumulation of immune mediators in the lesioned brain. Remarkably, emerging evidence suggests that activated microglia/macrophages polarize into distinct phenotypes to differentially regulate the microenvironment in the injured brain.
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in brain function under both physiological and pathological conditions. For example, T cell-derived IL-4 is important in learning and memory in the normal brain. 8 IL-4 levels in the brain decline with age, 9 perhaps contributing to cognitive decline in aged populations and increasing the risk for development of Alzheimer disease. Recent results from clinical and animal studies support the importance of IL-4 in the acute stages of stroke. In patients, serum levels of IL-4 increase significantly several hours after stroke onset. 10 IL-4 deficiency exacerbates brain injury and worsens neurological outcomes 24 hours after transient middle cerebral artery occlusion (tMCAO) in animal models of stroke, 11, 12 suggesting that IL-4 serves as an early endogenous neuroprotective mechanism soon after stroke onset. The effect of IL-4 on long-term recovery after stroke has not yet been explored although persistent recovery is more important for clinical translation.
In this report, we used IL-4 knockout (KO) mice to investigate the natural role of endogenous IL-4 in long-term neurobehavioral and neuropathological outcomes after focal cerebral ischemia. We discovered that IL-4 deficiency exacerbates sensorimotor and cognitive deficits ≤21 days after tMCAO or distal MCAO (dMCAO), and that this persistent effect is accompanied by impaired microglia/macrophage polarization toward the M2 phenotype. Conversely, the administration of IL-4 directly into the ischemic brain enhances functional recovery after stroke. Therefore, IL-4 is an important immune modulator serving to improve long-term outcomes after stroke, perhaps by regulating microglia/macrophage polarization and promoting an immune milieu that is highly permissive for behavioral recovery.
Materials and Methods

Animal Models
All animal experiments were approved by the University of Pittsburgh Institutional Animal Care and Use Committee and performed in accordance with the principles outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Wildtype (WT) or IL-4 KO male C57/BL6 mice (8-10 w, 25-30 g body weight; Jackson Laboratory, Bar Harbor, ME) were randomly assigned to sham or cerebral ischemia groups using a lottery drawing box. Transient focal ischemia was induced by MCAO for 60 minutes as previously described. 2 Sham-operated animals underwent anesthesia and exposure of the arteries without MCAO induction. Rectal temperature was maintained at 37.0±0.5°C during and after surgery with a temperature-controlled heating pad. Physiological parameters were maintained within normal ranges. Regional cerebral blood flow was monitored in all stroke animals using laser Doppler flowmetry. Animals that died or failed to show at least 70% regional cerebral blood flow reduction were excluded from further analyses. Mice in both genotypes were subjected to repeated measurements of CBF before ischemia, 5 minutes after tMCAO and 5 minutes after reperfusion using a laser speckle contrast imager (LDF, PeriFlux System 5000, Perimed). In all experiments, the tMCAO or sham surgeries were performed by an investigator blinded to genotype.
Intracerebroventricular IL-4 Administration
WT mice subjected to 60-minute MCAO or sham operation were randomly assigned to vehicle or IL-4 groups. An intracerebroventricular catheter was stereotaxically implanted into the ventricle contralateral to the lesion site (coordinates: −0.20 mm anterior and 1.00 mm lateral to bregma). An ALZET osmotic minipump containing IL-4 (Peprotech, 60 ng/d) or phosphate-buffered saline was implanted subcutaneously above the spine and connected to the intracerebroventricular catheter by an investigator blinded to experimental groups. The pump was programmed to achieve a constant infusion rate of 0.5 μL/h, starting from 6 hours after tMCAO. The pump was removed at 7 days after tMCAO.
Statistical Analysis
All data were reported as mean±SEM. Significant differences between means were assessed by 1-or 2-way ANOVA and post hoc least significant difference tests for multiple comparisons. The Student's t test was used for single comparisons. A P value <0.05 was deemed statistically significant. See the online-only Data Supplement for full description of experimental procedures.
Results
Increased Expression of the IL-4 Receptor in the Ischemic Brain
Previous studies report an early increase of IL-4 in the serum of patients with stroke. 10 We found that the expression of IL-4 mRNA in the mouse brain increased slightly but not significantly between 1 and 7 days after tMCAO and then collapsed on day 14 ( Figure 1A) . Interestingly, the expression of the 
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IL-4 receptor (IL-4Rα) was significantly elevated within 1 day after stroke, and this elevation was maintained for at least 14 days after stroke ( Figure 1B ). These findings reveal compensatory changes in the IL-4 pathway after stroke injury in vivo.
Loss of IL-4 Disrupts Long-Term Neurological Functions After Ischemic/Reperfusion Injury
Next, we used IL-4 KO mice to investigate the effect of IL-4 on long-term neurological outcomes after stroke. Transient focal ischemia was induced by 60-minute tMCAO. Physiological parameters, including blood pressure, blood gases, and glucose levels, exhibited no significant differences between WT and KO mice (not shown). Regional cerebral blood flow, as determined with a laser speckle contrast imager, did not differ by genotype before ischemia, 5 minutes after ischemia, or 5 minutes after reperfusion ( Figure 1C ). These findings verify that WT and IL-4 KO mice were subjected to the same ischemic insult during tMCAO and that any differences across genotypes cannot be attributed to variations in blood flow.
To determine the impact of IL-4 on functional outcomes after stroke, a battery of neurobehavioral tests were administered during both the acute and the long-term recovery stages after tMCAO. Although the sensorimotor outcomes were comparable between IL-4 KO and WT mice early after stroke, the KO mice exhibited much slower recovery over time, resulting in significant deterioration of behavioral performance at late stages after stroke. As shown in Figure 1D , the latency to fall off the Rotarod was much shorter in IL-4 KO mice than in WT mice at 5 to 9 days after stroke. Similarly, a protracted impairment in the corner test was observed in IL-4 KO mice at 9 to 14 days after tMCAO.
We further determined whether IL-4 deficiency impaired long-term cognitive functions using the Morris water maze test. The IL-4 KO and WT mice exhibited comparable cognitive functions after sham surgery under physiological conditions. However, long-term learning and memory deficits were significantly exacerbated in IL-4 KO mice after tMCAO, as manifested by an increased latency to find the hidden platform (impaired spatial learning ability) and reduced time spent in the target quadrant when the platform was removed (impaired memory) compared with WT mice (Figure 2A-2C ). Both the genotypes exhibited similar swim speeds ( Figure 2D ), suggesting equivalent swimming skills. Taken together, the results of the behavioral assays demonstrate a stable or persistent exacerbation of neurological dysfunction after stroke in the absence of IL-4.
IL-4 Deficiency Results in Early, Transient Enlargement of Infarct Size After Stroke
IL-4 KO mice exhibited greater infarct volumes than WT mice at 5 days after tMCAO, as measured by loss of microtubuleassociated protein 2 (MAP2) (marker of neuronal dendrites and somas, Figure 3 ) and NeuN (marker of neuronal nuclei, Figure I in the online-only Data Supplement). In contrast to the delayed deterioration of neurological functions shown in Figures 1 and 2 , the neuronal tissue loss in IL-4 KO mice was not significantly different from WT mice at 14 and 21 days after tMCAO ( Figure 3 ; Figure I in the online-only Data Supplement). These results suggest that endogenous IL-4 may delay neuronal death but cannot rescue neurons or reduce neuronal tissue loss over the long term.
Loss of IL-4 Shifts Microglia/Macrophage Polarization Toward M1
Recent studies have highlighted the importance of microglia/ macrophage polarity in the progression of brain injury and in brain repair. 13 IL-4 is known to induce microglia/macrophage polarization toward the beneficial M2 phenotype. Therefore, we explored whether the poor outcomes in IL-4 KO mice were associated with altered microglia/macrophage polarization after stroke. Real-time polymerase chain reaction measurements revealed the elevation of multiple M1-like markers, including CD16, tumor necrosis factor α, and inducible nitric oxide synthase (iNOS), at both 5 and 14 days after tMCAO in IL-4 KO mice ( Figure 4A ). Double immunostaining for CD16 and the microglia/macrophage marker Iba-1 confirmed that the number of CD16 + M1 microglia/macrophages was significantly increased in the striatum, but not in the cortex, in IL-4 KO mice after tMCAO ( Figure 4B-4D) . These results are consistent with an enhancement in M1 polarization and cerebral inflammation that extends into the late stages after stroke in IL-4 KO mice. Consistent with these findings, IL-4 KO mice exhibited reduced expression of M2-like markers (CD206 and IL-10) in the ischemic brain at both 5 and 14 days after tMCAO ( Figure 5A ). As shown by immunostaining, the number of CD206 + M2 microglia/macrophages was significantly decreased in IL-4 KO mice in both cortex and striatum at 14 days after stroke ( Figure 5B ). We then used flow cytometry to further characterize microglia (CD45 intermediate CD11b + ) and macrophages (CD45 high CD11b + ) during IL-4-induced M2 phenotype shifts. We found that IL-4 deficiency reduced the number of CD206 + macrophages in the ischemic brain ( Figure 5C ). The majority of resting microglia in the brain was CD206 + , although the expression level of CD206 per cell was relatively weak. Interestingly, the MCAO insult enhanced the mean fluorescence intensity of CD206 staining in each cell without increasing the total number of CD206 + microglia. These results suggest that resting microglia may already possess M2 properties that might be enhanced on stimulation. This notion is consistent with previous reports that M2 microglia show a greater tendency to maintain their M2 status. 14, 15 Compared with the flow cytometry results, the immunostaining revealed a more dramatic drop in the number of CD206 + microglia/macrophages in IL-4 KO stroke mice. This finding might be attributed to the relatively lower sensitivity and higher threshold for immunohistochemical detection of CD206 + , such that weakly positive cells in flow cytometry may be identified as negative by immunohistochemical staining. Taken together, our data suggest that endogenous IL-4 plays an important role in M2 microglia/macrophage polarization after stroke, which would be expected to facilitate long-term neurobehavioral recovery by creating an anti-inflammatory milieu.
IL-4 Deficiency Exacerbates Long-Term Neurological Functions and Impairs Microglia/ Macrophage M2 Polarization After Permanent dMCAO
Effects that can be generalized across different stroke models are more likely to translate to clinical studies. Thus, we also tested the effect of IL-4 in a model of permanent distal MCAO (dMCAO). The corner test revealed that dMCAO resulted in transient sensorimotor deficits early after surgery with a recovery by 9 days after dMCAO in WT mice. IL-4 deficiency significantly prolonged the sensorimotor deficits ( Figure 
Administration of IL-4 Improves Neurological Functions After Stroke Without Reducing Neuronal Loss
If loss of endogenous IL-4 leads to long-term neurological dysfunction, administration of exogenous IL-4 should have the converse effect and lead to stable recovery of function. Furthermore, if IL-4 protein levels are low 14 days after stroke injury but receptor levels are high, then one would expect IL-4 supplementation to be extremely effective at this time point. Thus, to further confirm the importance of IL-4 in persistent stroke recovery, recombinant IL-4 (60 ng/d) was continuously infused through an osmotic minipump into the brain of C57/ BL6 mice beginning 6 hours after tMCAO or sham operation and lasting for 1 week. Neurological functions were then assessed at various time points after surgery. IL-4 post treatment failed to improve neurobehavioral performance 1 to 7 days after tMCAO. However, at late stages after tMCAO, IL-4-treated mice showed improved performance in the Rotarod (14-35 days) and foot fault tests (21-35 days; Figure 6A -6B). Moreover, IL-4-treated mice exhibited improvements in cognitive functions, as manifested by improved spatial learning and memory in the Morris water maze ( Figure 6C ). Overall neuronal tissue loss was measured on NeuN-stained sections at 14 and 35 days after tMCAO but revealed no significant effect of IL-4 treatment ( Figure 6D ), entirely consistent with the IL-4 KO data.
Discussion
IL-4 is an important anti-inflammatory cytokine that is already known to protect the brain against acute ischemic injury.
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A recent study further suggests that IL-4 is essential for the resistance to acute brain ischemia observed during estrus in female animals. 13 However, the long-term influence of IL-4 on the pathophysiology of ischemic stroke remains elusive. In this study, we found a prolonged increase in mRNA levels of the IL-4R in the ischemic brain, suggesting that there is an increased response to IL-4 in both early and late stages after stroke. In contrast, IL-4 expression increases only slightly in the brain 1 to 7 days after stroke, followed by a dramatic decline at 14 days post injury. This transient IL-4 elevation might be attributed, at least partly, to the infiltration and accumulation of T cells, the major cellular source of IL-4, and other immune cells into the ischemic brain. 16 In addition, a recent study demonstrated that injured neurons may release IL-4 at acute stages of stroke. 17 These results suggest that increased signaling through the IL-4R may mitigate the inflammatory environment after stroke and lay the groundwork for recovery of neural function. Consistent with this hypothesis, we demonstrated that IL-4 deficiency significantly impairs sensorimotor and cognitive performance in 2 models of stroke, whereas IL-4 supplementation improves long-term functional outcomes after brain ischemia. These data strongly support a beneficial role for IL-4 in the recovery phase after stroke. Consistent with the present findings, population-based data demonstrate an association between IL-4 gene polymorphisms and functional outcomes after stroke and the incidence of poststroke depression. 18, 19 Therefore, boosting IL-4 levels is a promising therapeutic strategy to promote persistent and stable neurological recovery after stroke.
The importance of IL-4 in cognitive function under physiological conditions has been disputed. One early report suggested that IL-4 KO mice exhibit defects in spatial learning and memory capacities in the Morris water maze test. 8 However, a recent study using the same approach demonstrated comparable performance between IL-4-deficient mice and WT controls. 20 In addition, IL-4 KO mice performed normally in object location recognition tests (spatial memory) and novel object recognition tests (nonspatial memory), suggesting equivalent baseline cognitive functions between WT and IL-4 KO genotypes. 20 The present results confirm that sham IL-4 KO mice experience no changes in cognitive function in the Morris water maze. However, IL-4 deficiency significantly exacerbated cognitive dysfunction after stroke, demonstrating the importance of IL-4 in maintaining or restoring cognitive capacities under pathological conditions. IL-4-specific receptors are ubiquitously expressed in glial cells (microglia, astrocytes, and oligodendrocytes) as well as a variety of peripheral immune cells. 8, [11] [12] [13] [14] However, it is not known whether IL-4 targets cells in the central nervous system directly or exerts central protection indirectly by modifying peripheral immune responses after stroke. The increase in IL-4R in ischemic brain cells in this study is consistent with the view that IL-4 exerts at least some effects on the central nervous system. Furthermore, intraventricular IL-4 infusions improve long-term recovery after stroke, which is also consistent with the hypothesis that IL-4 elevation within the central nervous system directly acts on cells in the brain to mitigate the long-term neurological sequelae of stroke.
Microglia residing in the central nervous system, as well as centrally infiltrating macrophages, are established cellular targets of IL-4. 21, 22 Although IL-4 is well-known to induce microglia/macrophage polarization in vitro and in vivo in models of other neurological diseases, 23, 24 the effect of endogenous IL-4 on microglia/macrophage polarization status after stroke has not previously been investigated. Our data clearly show reductions in M2 microglia/macrophage polarization in both the striatum and the cortex of IL-4 KO mice, strongly supporting the importance of IL-4 in determining the M1/M2 equilibrium at both early and late stages after stroke. Because of the well-known protective or restorative effects of M2 microglia/macrophages in the injured brain, 13 the M2 phenotype shift observed in this study may be critical for long-term behavioral protection after stroke. Further studies are warranted to test the novel hypothesis that M2 induction by IL-4 after stroke injury serves as a natural brake on the progression of neurological dysfunction in vivo. Other M2-inducing cytokines, such as IL-10, have also been demonstrated to be protective in models of stroke. 25 Our data show that loss of IL-4 reduces the expression of IL-10 in the ischemic brain. Whether IL-4 works independently or in concert with IL-10 to modulate microglia/macrophage M2 polarization after stroke also deserves further investigation.
We have shown that the M1 phenotype exacerbates, whereas the M2 phenotype mitigates neuronal death under ischemic conditions.
2 Although IL-4 loss promoted the M1 phenotype and reduced M2 induction in this study, there was no significant long-term effect on neuronal loss, suggesting that microglia/macrophage polarization is probably necessary but not sufficient for neuroprotection. Because IL-4 deficiency increased neuronal loss at acute phases of stroke but did not seem to affect neuronal loss at late stages, it is possible that ≥1 neuron-independent mechanisms contribute to the long-term beneficial role of IL-4 in neurological functions. For example, recent evidence highlights the importance of white matter injury in long-term sensorimotor and cognitive deficits after stroke. 26 Indeed, some compounds have been shown to protect white matter integrity after stroke without any significant influence on gray matter, 27 suggesting that white matter protection may be achieved independent of neuronal protection. Therefore, white matter components may represent potential targets for IL-4 treatment in stroke victims. Consistent with these hypotheses, a protective role of IL-4 against white matter injury has been shown in a model of multiple sclerosis, in which IL-4 KO mice exhibited greater demyelination and functional deficits. 28 Furthermore, experiments using selective depletion of M1 or M2 phenotypic cells have confirmed that the M2 phenotype promotes, whereas the M1 phenotype impairs, white matter recovery after demyelination. 1 Further studies are warranted to confirm the effect of IL-4 on white matter integrity after stroke and further elucidate the cellular targets of IL-4.
Our current study focused on the long-term effect of IL-4 on stroke in males. Interestingly, recent studies support the importance of IL-4 in sex differences in stroke models. 12, 29 IL-4 is critical for neuroprotection during the estrus phase of the estrous cycle in females. 12 Furthermore, microglia isolated from female mice after MCAO express higher levels of the IL-4R on further inflammatory stimulation. 29 Therefore, the effect of IL-4 on long-term outcomes after stroke in female warrants further investigation. In summary, this study is the first to show that IL-4 stabilizes long-term behavioral performance after cerebral ischemia, possibly through a non-neuronal protective mechanism involving induction of the M2 phenotype in microglia/macrophages. These results might lead to development of new
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